HFF announces sale and financing of Lonza Viral Therapy Facility in Pearland, TX

Lonza Viral Therapy Facility, Pearland, TX

HOUSTON, TX –– HFF announces the sale and acquisition financing of the Lonza Viral Therapy Facility, a, 276,770-square-foot biotechnology facility in Pearland, Texas.

Jeff Hollinden

The HFF team represented the seller, Pinchal & Co, and procured the buyer, Zeller Realty Group (ZRG).  Additionally, HFF worked on behalf of ZRG to secure the fixed-rate acquisition loan through Bank of Texas.   

Completed in the fourth quarter 2017, the Lonza Viral Therapy Facility is fully-leased on a long-term, triple net basis to Lonza America, Inc., a wholly owned subsidiary of Lonza Group AG, a leading Swiss biotechnology and pharmaceutical company. 

The property is touted as the world’s largest cell and gene therapy facility housing office space, a process development unit, quality control laboratories, a fully segregated fill/finish suite and independent modular cleanrooms designed to manufacture cell therapy products. 

The facility is situated on 11.01 acres at 14905 Kirby Drive in Pearland’s rapidly growing Lower Kirby Urban District.  The Lower Kirby Urban District is a 1,200-acre site that seeks to become a primary life science destination building upon its location at the intersection of Beltway 8 and State Highway 288, just eight miles south of the Texas Medical Center, the largest medical district in the world.

Cameron Cureton

HFF’s investment advisory and debt placement teams included senior managing director Jeff Hollinden and senior director Cameron Cureton.

Holliday GP Corp. (“HFF”) is a Texas licensed real estate broker.

 For more information, please contact:

KRISTEN MURPHY

HFF Director, Public Relations

(617) 338-0990

krmurphy@hfflp.com

 www. zellerrealty.com.